For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit

A POC Clinical Trial for PTSD with a First­-in-­Class Vasopressin 1a Receptor Antagonist


Have you experienced: A trauma that exposed you to threatened death, serious injury or sexual violence? Examples include: motor vehicle accidents, natural disasters, assault, work-related trauma, childhood trauma, and fires.

Do you experience: Unwanted memories? Flashbacks? Sleep problems?  Nightmares? Difficulty concentrating? Nervousness, jumpiness, or anxiety? Irritability or anger? Depression? Just not feeling yourself anymore?

If you are between the ages of 18-65 and have symptoms of PTSD for at least one month, you may be eligible to participate.


We are seeking participants for a clinical trial which will test an experimental drug for the treatment of Post-Traumatic Stress Disorder (PTSD).



Following the initial screening phase, you will receive the medication treatment for 8 weeks and the placebo for 8 weeks. The study will last a total of 18 weeks, and you will be assessed at baseline and then every 2 weeks until the end of the study. You will be compensated for all completed assessments (up to a total of $400).

To schedule an evaluation or to learn more about the study, please contact us at 212-821-0783

Study Flyer

Manhattan Offices

425 East 61st Street
New York, NY 10065

435 East 70th Street
New York, NY 10021

Westchester Office

21 Bloomingdale Road
White Plains, NY 10605